Identification of mutations in BTG1 and B2M genes associated with early disease progression and/or histological transformation (42) exclusively in the plasma cfDNA sample of a FL case suggests that plasma cfDNA genotyping may provide additional prognostic information that may not be obtained from tumor tissues under certain circumstances. This evidence concerns the gene BTG1 and neoplasm.